Results 171 to 180 of about 1,114,936 (208)
Some of the next articles are maybe not open access.
Management of inflammatory choroidal neovascular membranes
Expert Review of Ophthalmology, 2020Introduction: Inflammatory choroidal neovascularization (iCNV) is a significant complication of uveitis, leading to vision loss in many cases.
Rachael Niederer +7 more
openaire +1 more source
Inflammatory Choroidal Neovascularization: Beyond the Intravitreal Approach
Ocular Immunology and Inflammation, 2017To describe the importance of a customized combined systemic and local therapy in the management of inflammatory choroidal neovascularization (iCNV).Observational retrospective case series.Four iCNV cases, complicating posterior uveitis or panuveitis affecting young patients, are reported.
Cerquaglia, Alessio +4 more
openaire +2 more sources
Eicosapentaenoic Acid Is Anti-Inflammatory in Preventing Choroidal Neovascularization in Mice
To investigate the role of eicosapentaenoic acid (EPA), the major omega-3 polyunsaturated fatty acid (PUFA), in the development of choroidal neovascularization (CNV), together with underlying molecular mechanisms.Six-week-old C57BL/6 mice were fed with laboratory chow with 5% EPA or the omega-6 PUFA linoleic acid (LA) for 4 weeks.
Hajime Shinoda +2 more
exaly +3 more sources
BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION RELATED TO INFLAMMATORY DISEASES
Retina, 2010The purpose of this study was to report our experience with intravitreal bevacizumab for inflammation-related choroidal neovascularization in two tertiary centers.This study was a retrospective analysis of patients with choroidal neovascularization related to inflammatory diseases, treated with intravitreal bevacizumab injections (1.25 mg/0.05 mL).Ten ...
Michal, Kramer +10 more
openaire +2 more sources
Inflammatory choroidal neovascularization: An evidence-based update
Survey of OphthalmologyInflammatory choroidal neovascularization (iCNV) significantly contributes to vision impairment and ranks as the third primary cause of CNV. Arising from both infectious and noninfectious uveitis, iCNV's pathogenesis involves Bruch membrane rupture, local inflammation, and choriocapillaris ischemia.
Maria V Cicinelli +2 more
exaly +4 more sources
Diagnostic Challenges in Inflammatory Choroidal Neovascular Membranes
Ocular Immunology and Inflammation, 2016To describe the clinical presentations of inflammatory choroidal neovascular membranes (CNVMs) and factors leading to their delayed diagnosis.Retrospective analysis of chart records and digital images of 60 patients (73 eyes) with inflammatory CNVM (January 1998 to December 2013) to obtain demographic and clinical details, particularly the time of the ...
Reema, Bansal +6 more
openaire +2 more sources
Effects of Intravitreal Bevacizumab on Inflammatory Choroidal Neovascular Membrane
European Journal of Ophthalmology, 2012Purpose. To test the efficacy of intravitreal bevacizumab (IB) in the treatment of inflammatory choroidal neovascularization (CNV). Methods. A prospective interventional study on patients with subfoveal CNV secondary to posterior ...
Iannetti L +5 more
openaire +5 more sources
Review for Diagnostics of the Year: Inflammatory Choroidal Neovascularization – Imaging Update
Ocular Immunology and Inflammation, 2022Inflammatory choroidal neovascularization (iCNV) is a rare complication of uveitis but is a major cause of vision compromise in affected patients. Fluorescein angiography (FA) has been the gold standard for diagnosis. However, it is an invasive modality and when used alone, it might be difficult to distinguish iCNV from inflammatory lesions.
Ghazi Bou Ghanem +4 more
openaire +2 more sources
Serum Inflammatory Factors in Patients with Idiopathic Choroidal Neovascularization
Ocular Immunology and Inflammation, 2010To investigate serum inflammatory factors in patients with idiopathic choroidal vascularization (CNV), including vascular endothelial growth factor (VEGF), tumor necrosis factor alpha (TNFα), Interleukin1-beta (IL1-β), IgG, IgA, IgM, IgE, 50% hemolytic unit of complement (CH50), complement C3, complement C4 and C reactive protein (CRP).21 patients and ...
Fan, Yang +6 more
openaire +2 more sources
Acta Ophthalmologica, 2022
AbstractPurposeTo evaluate mean change in best‐corrected visual acuity (BCVA) at 52 weeks in patients with inflammatory choroidal neovascularization (CNV) treated with aflibercept.MethodsWe conducted a prospective non‐comparative open‐label trial. Following one mandatory intravitreal injection of aflibercept, patients were treated under a pro re nata ...
Kodjikian, Laurent +11 more
openaire +2 more sources
AbstractPurposeTo evaluate mean change in best‐corrected visual acuity (BCVA) at 52 weeks in patients with inflammatory choroidal neovascularization (CNV) treated with aflibercept.MethodsWe conducted a prospective non‐comparative open‐label trial. Following one mandatory intravitreal injection of aflibercept, patients were treated under a pro re nata ...
Kodjikian, Laurent +11 more
openaire +2 more sources

